Regenerative MedicineStem Cell Transplants Show Early Safety Promise for Parkinson's Disease
Scientists transplanted lab-grown dopamine-producing cells derived from human embryonic stem cells into the brains of eight people with moderate Parkinson's disease. After 12 months, the procedure appeared safe: no tumors formed, no abnormal movements caused by the graft were detected, and no serious side effects were linked to the cells themselves. One participant died from a lung infection unrelated to the cell product. The main risks came from the immunosuppressive drugs needed to prevent rejection. This is one of the first human trials to use a ready-made, off-the-shelf stem cell product for Parkinson's, marking a significant step toward a potentially restorative treatment that could one day replace the brain cells lost to the disease.
